Preventive Cardiology after Framingham: Nathan D. Wong, PhD, MPH, Details the Evolution
July 28th 2021Nathan D Wong, PhD, MPH, renowned in the field of preventive cardiology, reviewed for Patient Care the history of the field and his own pivotal contributions and also paid tribute to his lifetime mentors.
Low-dose Rivaroxaban plus Aspirin Effective in CAD/PAD Regardless of Multimorbidity, Polypharmacy
July 15th 2021In patients with stable vascular disease from the COMPASS trial, the combination of rivaroxaban and aspirin effectively reduced ischemic events despite multiple comorbidities and polypharmacy.